Malignant tumours differ mostly from benign lesions in their blood sup
ply. This fact can be used in the sonographic diagnosis of the tumour
status. This, however, depends on the availability of ultrasound equip
ment, capable of demonstrating this difference, which can only be dete
cted in smallest blood vessels, in which the blood flow is extremely s
low. We employed the Sonolayer SSH 140A (Toshiba, Japan) and the Quant
um 2000 (Siemens, Germany) for diagnosis of lesions of the female inne
r genital tract. Both instruments could visualize the slow blood flow
velocities in the tissues examined. Diagnosis of blood circulation in
tumours of the inner genital tract thus seems less dependent on the te
chnology employed as is the case in examining the breasts. 41 patients
with ovarian tumours, 31 with endometrial pathology, and 33 with cerv
ical lesions were examined preoperatively. Findings were correlated to
histology. The lowest resistance index (RI) measured was evaluated. T
he following RI values were found: Ovarian tumours: malignant 46 %, be
nign 78 % (49 %) Tumours of the corpus uteri: malignant 54 benign 65 %
(55 %) Cervical lesions: malignant 55 %, benign 79 % (58 %) Results i
n premenopausal women with non-malignant lesions are specified in brac
kets. Pre- and postmenopausal status proved essential. When compared t
o breast findings, the difference between benign and malignant tumours
of the inner genital tract is less pronounced due to the fact, that,
physiologically, these tissues are characterised by a higher blood sup
ply. Differentiation was thus almost impossible in premenopausal women
. However, in menopausal patients, a highly significant difference bet
ween benign and malignant tumours was found, which could serve as basi
s for tumour status prognosis. Hormone therapy in the post-menopause m
ay, however, influence blood supply so much, that differentiation agai
n becomes almost impossible. Despite these problems still inherent to
the method, ultrasonic examination of blood supply in lesions of the i
nner genital tract seems to be a valuable procedure for tumour status
prognosis in postmenopaused patients.